Rheumatoid Arthritis Clinical Trials in New York, New York

6 studies are recruiting for rheumatoid arthritis in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Exactech Shoulder Post Market Clinical Follow-up Study

   The objective of this study is to collect and evaluate long-term clinical and radiographic outcomes data in order to better understand the safety and performance of the shoulder arthroplasty over time. This study will follow subjects long-term for a minimum of 10-years, without an early-term restri…

   Stage

   Not phased

   Ages

   21 and older

   Site

   Hospital for Joint Diseases - NYU Langone Health, New York, New York

   Locations

   40 in total

   Run by

   Exactech

   See if you can join NCT05603728 on ClinicalTrials.gov

2. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

   This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York

   Locations

   52 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT03816345 on ClinicalTrials.gov

3. A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

   This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune diseases.

   Stage

   Phase 1

   Ages

   18 to 75

   Site

   Nkarta Investigational Site, New York, New York

   Locations

   18 in total

   Run by

   Nkarta, Inc.

   See if you can join NCT06733935 on ClinicalTrials.gov

4. A Study of AZD0120 in Autoimmune Diseases

   This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with systemic sclerosis (SSc), idiopathic inflammatory myopathies (IIM), or difficult-to-treat rheumatoid arth…

   Stage

   Phase 1

   Ages

   18 to 75

   Site

   Research Site, New York, New York

   Locations

   22 in total

   Run by

   AstraZeneca

   See if you can join NCT07295847 on ClinicalTrials.gov

5. RA-PRO PRAGMATIC TRIAL

   The 2021 ACR RA treatment guideline, based on widely acknowledged low to moderate quality evidence, recommends switching to a non-tumor necrosis factor (TNFi) biologic (choose among existing medications, currently, rituximab, abatacept, tocilizumab, or sarilumab) or a targeted synthetic DMARD arm (…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   New York University, New York, New York

   Locations

   49 in total

   Run by

   University of Alabama at Birmingham

   See if you can join NCT04692493 on ClinicalTrials.gov

6. Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis

   The condition that will be studied is Rheumatoid Arthritis (RA), and in particular, RA patients with moderate to highly active disease who were prescribed Abatacept (Orencia®) (ABA) by their physician during their setting of care at Hospital for Special Surgery (HSS). This investigator-initiated, p…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Hospital for Special Surgery, New York, New York

   Run by

   Hospital for Special Surgery, New York

   See if you can join NCT05782335 on ClinicalTrials.gov